Vaccine News and Research

Latest Vaccine News and Research

Benefit from convalescent plasma shown in COVID outpatient trial

Researchers have conducted a double-blind, multicentre, randomized, controlled trial, which is known as Convalescent Plasma to Limit SARS-CoV-2 Associated Complications Study to evaluate if early COVID-19 plasma treatment could reduce disease progression and, thereby, reduce hospitalization rate.

9 May 2022

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

A new study published in the New England Journal of Medicine has discussed the efficacy and safety profile of the ZF2001 vaccine in adults, based on a randomized, placebo-controlled, multinational, double-blind phase 3 trial.

9 May 2022

Infection with SARS-CoV-2 results in antibodies against common colds

A study published in the journal Science Advances uses electron microscopy-based polyclonal epitope mapping (EMPEM) methodology to elucidate the spike epitopes of β-HCoV targeted by preexisting serum antibodies and compares them to the epitopes targeted by antibodies elicited by SARS-CoV-2 infection using electron microscopy-based polyclonal epitope mapping (EMPEM) methodology.

8 May 2022

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).

6 May 2022

Sweeping, limited, or no powers at all? What’s at stake in the mask mandate appeal

The definition of "sanitation." An old court case that involves an underwear manufacturer. Whether people had a fair chance to express their opinions about wearing masks on planes.

6 May 2022

A guide to help you keep up with the omicron subvariants

Two years into the coronavirus pandemic, Americans can be forgiven if they've lost track of the latest variants circulating nationally and around the world. We've heard of the alpha, beta, gamma, delta, and omicron variants, but a new Greek-letter variant hasn't come onto the scene in almost half a year.

6 May 2022

Prenatal exposure to SARS-CoV-2 raises risk of neurological disorders in infants

In a recent study published in the journal PLOS One, researchers investigated the early indicators of neurological dysfunctions, including the absence of fidgety movements, in three to five-month-old infants prenatally exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 May 2022

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer’s disease, according to new research reported at the Alzheimer’s Association International Conference 2020.

5 May 2022

Racial and ethnic discrimination in a medical setting linked with COVID-19 vaccine refusal

A new study examining the associations between racial and ethnic discrimination and COVID-19 vaccine refusal has found that one in ten people from ethnic minority groups who refused a vaccine experienced racial discrimination in a medical setting since the start of the pandemic.

5 May 2022

World's first malaria vaccine may be available soon across Sub-Saharan Africa

The world's first malaria vaccine will soon be available across Sub-Saharan Africa, according to PATH, partners of the vaccine developers, as positive results from the pioneering jab pile up.

5 May 2022

Health Secretary takes action to ensure more women can access HRT products

Urgent action continues to be taken to ensure women across the UK will be able to more reliably access HRT products.

5 May 2022

Crucial discovery could inform potential strategies to control malaria transmission

WEHI researchers in Melbourne have made a crucial discovery about how asymptomatic malaria infections impact the body, informing potential strategies to control transmission and improve treatment outcomes.

5 May 2022

Evaluating the findings of phase 3 clinical trial of plant-based COVID-19 vaccine

A new study has presented the safety and efficacy profiles of a plant-based adjuvanted coronavirus disease 2019 (COVID-19) vaccine in human participants.

5 May 2022

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

Researchers assessed the induction of variant-specific neutralizing antibodies against the SARS-CoV-2 spike and nucleocapsid proteins of several SARS-CoV-2 strains.

5 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Researchers assessed the emergence and evolution of SARS-CoV-2 Omicron variant in South Africa.

5 May 2022

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

In a recent study posted to the Research Square* preprint server, researchers tested the safety and immunogenicity of a third dose of coronavirus disease 2019 (COVID-19) prototype messenger ribonucleic acid (mRNA)-1273 versus a variant vaccine and a bivalent vaccine formulation.

5 May 2022

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

A recent study posted to the bioRxiv* preprint server demonstrated that the latest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages evade immunity imparted by the prior subvariants.

5 May 2022

Oral Nirmatrelvir's effects on long COVID symptoms

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined the cases of three individuals who received nirmatrelvir/ritonavir antiviral therapy at different stages following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

4 May 2022

New study helps explain the immune system’s response to skin infections and skin cancers

It is well established that older adults are more susceptible to infection and their immune systems less capable of generating a strong immune response.

4 May 2022

Vaccine News and Research

Latest Vaccine News and Research

Benefit from convalescent plasma shown in COVID outpatient trial

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

Infection with SARS-CoV-2 results in antibodies against common colds

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

Sweeping, limited, or no powers at all? What’s at stake in the mask mandate appeal

A guide to help you keep up with the omicron subvariants

Prenatal exposure to SARS-CoV-2 raises risk of neurological disorders in infants

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Racial and ethnic discrimination in a medical setting linked with COVID-19 vaccine refusal

World's first malaria vaccine may be available soon across Sub-Saharan Africa

Health Secretary takes action to ensure more women can access HRT products

Crucial discovery could inform potential strategies to control malaria transmission

Evaluating the findings of phase 3 clinical trial of plant-based COVID-19 vaccine

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

Evaluation of the potential of new and repurposed TB vaccines

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

Oral Nirmatrelvir's effects on long COVID symptoms

New study helps explain the immune system’s response to skin infections and skin cancers

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in